Obama boosts Alzheimer's funding by $130 million

Kathleen Sebelius, Secretary of Health and Human Services, announced today that the Obama administration would increase funding for Alzheimer’s disease research by $130 million.   An extra $50 million will be made available immediately, and another $80 million will be added to the fiscal year 2013 federal budget to be released next week.  In total, this funding represents a 25% increase in funding for Alzheimer’s disease research over the next two years.  An additional $25 million will be allocated for caregiver support, provider education, public awareness, and improvements in data infrastructure.  “We can’t wait to confront the growing threat that Alzheimer’s disease poses to American families and to our nation as a whole,” noted Sebelius.   Increased funding comes on the heels of the recent announcement that first goal of  the National Alzheimer’s Project Act is

to prevent and effectively treat Alzheimer’s disease by 2025

Nationwide, 5.4 million people have AD and rely on 14.9 million close family members and friends for care.  In California, AD currently affects nearly 500,000 people, a number that is expected to escalate to 1.1 million by 2030.  With an average of three caregivers supporting each of these 1.1 million people, the number of Californians coping with AD will total an estimated 4.4 million in 2030. more >

Aimee Pierce, M.D., Named Medical Director

Dr. Aimee Pierce, Assistant Clinical Professor in UCI’s Department of Neurology, has been named Medical Director of the UCI MIND Memory Assessment Clinic.  Hailing from Eugene, Oregon, Dr. Pierce earned her B.S. in Biology at the California Institute of Technology in Pasadena, CA, and her M.D. more >

UCI MIND Launches MIND Matters Club

Dr. Frank LaFerla, Dr. Margaret Gatz, and Dr. Cordula Dick-Muehlke at MIND Matters Club Launch

On January 19, UCI MIND launched the MIND Matters Club at the home of Burton and Linda Young, who graciously hosted this inaugural gathering of individuals who have committed to  giving $1,906 or more annually to UCI MIND.  Guests gathered to hear Dr. more >

Join us for the 3rd Annual ReMIND Emerging Scientists Symposium!

The graduate student group ReMIND and the UCI MIND Institute will be hosting the Emerging Scientists Symposium on Neurological Disorders on February 9th at the University Club. It is a unique opportunity for graduate and postdoctoral researchers to present their work. more >

Watch our 2011 Alzheimer’s disease annual conference

Please click on the following links to watch each of the presenters at our 2012 Alzheimer’s disease annual conference:

19th Annual Southern California
Alzheimer’s Disease Research Conference

When Does It Become Dementia?
Transitioning from Healthy Aging to MCI and Dementia

September 30, 2011


McGaugh – Making Lasting Memories
Morris – Redefining Alzheimer’s Disease: The Danger of Revised Criteria for Mild Cognitive Impairment
Kawas – Diagnosing Alzheimer’s Before Memory Loss Sets In: Proposed Research Criteria
Snyder – When the Diagnosis is Early-Stage Alzheimer’s: What Happens Next? more >

19th Annual Southern California Alzheimer’s Disease Research Conference

Read all about it at the OC Register.  Click Here. more >

Making memories last

With Alzheimer’s a looming public health crisis, UCI MIND’s director discusses promising research.  Click here to read the full story

more >

19th Annual Southern California Alzheimer’s Disease Research Conference

When Does It Become Dementia?

Transitioning from Healthy Aging to MCI and Dementia

September 30, 2011 at the Irvine Hilton, Irvine


The UCI Institute for Memory Impairments and Neurological Disorders (UCI MIND) at the University of California, Irvine, the Alzheimer’s Association Orange County Chapter, and Alzheimer’s Family Services Center are pleased to announce the 19th Annual Southern California Alzheimer’s Disease Research Conference, When Does It Become Dementia? more >

Frontiers of the MIND 2011

September 21, 2011,

Frontiers of the MIND focusing on Traumatic Brain Injury

Featuring Ann McKee, M.D. , Boston University

Dr. McKee’s research interests center on the neuropathological alterations of neurodegenerative diseases, with a primary focus on the role of tau protein, axonal injury, trauma, vascular injury, and neurodegeneration. more >

Medications to avoid for patients

Medications and Patients with Alzheimer’s Disease – What to Avoid

Gaby T. Thai, M.D.
Doctors are often asked whether there are any medications that someone with Alzheimer’s disease should avoid. Patients with Alzheimer’s disease may need medicines to treat symptoms of the disease, as well as for other health problems such as bladder incontinence, mood disturbances, high blood pressure, etc…  However, when a person takesmany medications, there is an increased risk of adverse effects, including confusion, mood swings, sleepiness, andworsening memory problems. more >